Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.24 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMII) Preferred Stock Liabilities (2025 - 2026)

Updated

Drugs Made In America Acquisition (DMII) reported Preferred Stock Liabilities of $513.88 million for Q2 2026, up 0.9% from the prior quarter.

Analysis

Drugs Made In America Acquisition (DMII) Preferred Stock Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition posted Preferred Stock Liabilities of $504.93 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $509.37 million (Q1 2026), $504.93 million (Q4 2025) and $500.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - -
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - -
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 3.25 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - -
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn -
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn -
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn 25.75 Mn
10 Drugs Made In America Acquisition 652.29 Mn 651.45 Mn - 513.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 513.88 Mn
Mar 31, 2026 509.37 Mn
Dec 31, 2025 504.93 Mn
Sep 30, 2025 500.11 Mn
API Access

Drugs Made In America Acquisition Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=DMII&period=max&api_key=YOUR_API_KEY